Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-13

Clinical Trial Update: Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial investigating LNG-IUS as a fertility-preserving treatment for endometrial cancer and atypical endometrial hyperplasia is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LNG-IUS (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: West China Second University Hospital | Conditions: Endometrial Cancer, Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: RECRUITING